A MedPage Today article reports that as Great Britain continues to stretch out the interval between the first and second doses of the COVID-19 vaccine to 12 weeks, data out this week seems to support doing so, but concerns remain. A study published in The Lancet showed that the AstraZeneca/Oxford vaccine provides sustained protection of 76% during the 12-week interval …
Following a recent concern raised around thrombotic events, AstraZeneca issued a press release to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence. Safety is of paramount importance and the company is continually monitoring the safety of its vaccine. A careful review of all available safety data of more than 17 million people vaccinated …
